The JAK-STAT pathway at 30: Much learned, much more to do

RL Philips, Y Wang, HJ Cheon, Y Kanno, M Gadina… - Cell, 2022 - cell.com
The discovery of the Janus kinase (JAK)-signal transducer and activator of transcription
(STAT) pathway arose from investigations of how cells respond to interferons (IFNs) …

JAK–STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects

S Banerjee, A Biehl, M Gadina, S Hasni, DM Schwartz - Drugs, 2017 - Springer
The Janus kinase/signal transduction and activator of transcription (JAK–STAT) signaling
pathway is implicated in the pathogenesis of inflammatory and autoimmune diseases …

Highly selective inhibition of tyrosine kinase 2 (TYK2) for the treatment of autoimmune diseases: discovery of the allosteric inhibitor BMS-986165

ST Wrobleski, R Moslin, S Lin, Y Zhang… - Journal of Medicinal …, 2019 - ACS Publications
Small molecule JAK inhibitors have emerged as a major therapeutic advancement in
treating autoimmune diseases. The discovery of isoform selective JAK inhibitors that …

Glycolytic stimulation is not a requirement for M2 macrophage differentiation

F Wang, S Zhang, I Vuckovic, R Jeon, A Lerman… - Cell metabolism, 2018 - cell.com
Enhanced glucose uptake and a switch to glycolysis are key traits of M1 macrophages,
whereas enhanced fatty acid oxidation and oxidative phosphorylation are the main …

The role of JAK/STAT pathway in fibrotic diseases: molecular and cellular mechanisms

J Liu, F Wang, F Luo - Biomolecules, 2023 - mdpi.com
There are four members of the JAK family and seven of the STAT family in mammals. The
JAK/STAT molecular pathway could be activated by broad hormones, cytokines, growth …

Interferon gamma induces reversible metabolic reprogramming of M1 macrophages to sustain cell viability and pro-inflammatory activity

F Wang, S Zhang, R Jeon, I Vuckovic, X Jiang… - …, 2018 - thelancet.com
Classical activation of M1 macrophages with lipopolysaccharide (LPS) is associated with a
metabolic switch from oxidative phosphorylation to glycolysis. However, the generalizability …

[HTML][HTML] The regulation of JAKs in cytokine signaling and its breakdown in disease

HM Hammarén, AT Virtanen, J Raivola, O Silvennoinen - Cytokine, 2019 - Elsevier
The JAK–STAT signal transduction pathway is responsible for mediating signals of over fifty
cytokines, growth factors and hormones. Signaling through the JAK–STAT pathway is …

Prospects for pharmacological targeting of pseudokinases

JE Kung, N Jura - Nature Reviews Drug Discovery, 2019 - nature.com
Pseudokinases are members of the protein kinase superfamily but signal primarily through
noncatalytic mechanisms. Many pseudokinases contribute to the pathologies of human …

[HTML][HTML] Pathogenesis of myeloproliferative neoplasms

RC Skoda, A Duek, J Grisouard - Experimental hematology, 2015 - Elsevier
Major progress has been recently made in understanding the molecular pathogenesis of
myeloproliferative neoplasms (MPN). Mutations in one of four genes—JAK2, MPL, CALR …

Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases

A Hosseini, T Gharibi, F Marofi… - Journal of Cellular …, 2020 - Wiley Online Library
Many cytokines are crucial drivers of cancers and autoimmune conditions. These proteins
bind to receptors and signal their responses through Janus kinase (JAK) and signal …